Browse CATs

Browse CATs  internal medicine  cardiology  atrial fibrillation

Diagnosis Economics Harm/ aetiology Prognosis Therapy Anticoagulation Cardioversion  - electrical  - pharmacological Rate control Maintenance

Atrial fibrillation DC cardioversion guided by transesophageal echocardiography led to fewer bleeds. Level of evidence 1b Expiry Date November 2003 Atrial fibrillation DC cardioversion: an initial shock of 360 J was more effective than lower energies Level of evidence 1b Expiry Date November 2003 Atrial fibrillation cardioversion: transoesophageal echocardiography did not reduce subsequent embolic events. Level of evidence 2a Expiry Date August 2004 Atrial fibrillation paroxysmal: patients felt better with AV junction ablation and a pacemaker rather than AV junction modification Level of evidence 1b Expiry Date November 2003 Atrial fibrillation radiofrequency modulation of the AV node helped symptoms. Level of evidence 4 Expiry Date November 2003 Atrial fibrillation DC cardioversion: anticoagulation reduced embolic events. Level of evidence 4 Expiry Date November 2003 Atrial fibrillation cardioversion: anteroposterior pads were not clearly better than anteroanterior pads Level of evidence 1b- Expiry Date November 2002 Atrial fibrillation, atrial flutter paroxysmal: sotalol 120 mg twice daily reduced recurrent symptomatic episodes. Level of evidence 1b Expiry Date January 2004 Atrial fibrillation ibutilide before DC cardioversion increased initial success. Level of evidence 1b Expiry Date July 2003 Atrial fibrillation chronic: no clear role for propafenone before DC cardioversion. Level of evidence 1b Expiry Date November 2003 Cardioversion anticoagulation reduced embolic events. Level of evidence 4 Expiry Date June 2004